Effect of house dust mite sublingual immunotherapy in IgE and IgG4 responses to Der p 1, Der p 2 and Der p 10 and IgE to S. aureus enterotoxins in patients with Atopic Dermatitis: a randomized, double-blind, placebo-controlled study

Abstract

We have shown that sublingual immunotherapy (SLIT) with house dust mite (HDM) extract was beneficial to patients with atopic dermatitis (AD), decreasing signs and symptoms of AD in a randomized, double-blind, placebo-controlled trial (Langer et al JACI Pract 2021 In press). We aimed to investigate IgE and IgG4 responses to HDM allergens and IgE to Staphylococcus aureus exotoxins in the study patients.